A
Aminah Jatoi
Researcher at Mayo Clinic
Publications - 440
Citations - 15796
Aminah Jatoi is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 46, co-authored 404 publications receiving 12708 citations. Previous affiliations of Aminah Jatoi include University of Texas Health Science Center at San Antonio & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma
Ping Yang,Kimary Kulig,Jennifer M. Boland,Michele R. Erickson-Johnson,Andre M. Oliveira,Jason A. Wampfler,Aminah Jatoi,Claude Deschamps,Randolph S. Marks,Connie Fortner,Shawn M. Stoddard,Francis C. Nichols,Julian R. Molina,Marie Christine Aubry,Hui Tang,Eunhee S. Yi +15 more
TL;DR: The findings suggest that ALK positivity is associated with a significantly poor outcome in nonsmoking-related adenocarcinoma and that ALk-positive tumors may be associated with an increased risk of brain and liver metastases compared with ALK-negative disease.
Journal Article
Preoperative testing before noncardiac surgery: guidelines and recommendations.
Molly A. Feely,C. Scott Collins,Paul R. Daniels,Esayas B. Kebede,Aminah Jatoi,Karen F. Mauck +5 more
TL;DR: Preoperative testing (e.g., chest radiography, electrocardiography, laboratory testing, urinalysis) is often performed before surgical procedures, but often are obtained because of protocol rather than medical necessity.
Journal ArticleDOI
Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group
Aminah Jatoi,Shauna L. Hillman,Philip J. Stella,Erin M. Green,Alex A. Adjei,Suresh G. Nair Md,Edith A. Perez,Bipinkur Amin,Steven E. Schild,Rene Castillo,James R. Jett +10 more
TL;DR: It seems that elderly-specific trials are providing quality care and helping to define optimal cancer therapy in the elderly, particularly among the "oldest of the old."
Journal ArticleDOI
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
Aminah Jatoi,Shaker R. Dakhil,Phuong L. Nguyen,Jeff A. Sloan,John W. Kugler,Kendrith M. Rowland,Gamini S. Soori,Donald B. Wender,Tom R. Fitch,Paul J. Novotny,Charles L. Loprinzi +10 more
TL;DR: Whether etanercept (a dimeric fusion protein consisting of the extracellular ligand‐binding portion of the human 75‐kilodalton TNF receptor linked to the Fc portion of human immunoglobulin [Ig] G1) could palliate this syndrome is investigated.
Journal ArticleDOI
Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review
Richard F. Dunne,Kah Poh Loh,Kah Poh Loh,Grant R. Williams,Aminah Jatoi,Karen M. Mustian,Karen M. Mustian,Supriya G. Mohile,Supriya G. Mohile +8 more
TL;DR: Formal treatment guidelines, an updated consensus definition for cancer cachexia and the development of a widely adapted assessment tool, much like the GA utilized in geriatric oncology, could help advance the field of cancer Cachexia over the next decade.